United Therapeutics
Builds pulmonary-hypertension medicines and investigational organ-manufacturing platforms.
$515.46
After-hours close+0.15 (+0.03%)
At close$515.31(−2.39%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 177.21%Insiders 1.21%
A 13F quarter can total more than the shares outstanding — sub-advisers file the same block twice, and a filer's own share count can be a quarter stale. No split is drawn from it.
Shares outstanding 42.45M · Float 39.32M · 92.6% free float
Institutions13F, as of Jun 30, 2026
896 holders · 75.22M shares · 105 new positions · 423 increased · 334 reduced · 85 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 5.29M | 12.47% | −105.1K | Aug 7, 2026 |
| Avoro Capital Advisors LLC | 2.78M | 6.54% | +147.8K | Aug 14, 2026 |
| Vanguard Portfolio Management LLC | 1.92M | 4.52% | −84.3K | Aug 13, 2026 |
| Vanguard Capital Management LLC | 1.92M | 4.52% | −39.3K | Aug 13, 2026 |
| State Street Corp | 1.90M | 4.47% | +54.1K | Aug 7, 2026 |
| Renaissance Technologies LLC | 1.71M | 4.03% | −78.3K | Aug 13, 2026 |
| Wellington Management Group LLP | 1.38M | 3.25% | −885.2K | Aug 14, 2026 |
| Geode Capital Management, LLC | 996.6K | 2.35% | −236.4K | Aug 12, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Wellington Management Group LLP | 5.70% | 2.44M | 13G | Feb 10, 2026 ↗ |
| Vanguard Capital Management | 5.19% | 2.28M | 13G | Apr 30, 2026 ↗ |
| State Street Corporation | 5.00% | 2.24M | Oct 16, 2024 ↗ |
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| Martine A. Rothblatt | director, officer: Chairperson & CEO | 365.0K | 0.86% | Aug 28, 2026 |
| Paul A. Mahon | officer: EVP & GENERAL COUNSEL | 45.2K | 0.11% | Aug 21, 2026 |
| Richard Giltner | director | 21.9K | 0.05% | Jul 13, 2026 |
| James Edgemond | officer: CFO AND TREASURER | 18.9K | 0.04% | Jun 23, 2026 |
| Michael Benkowitz | officer: PRESIDENT AND COO | 17.8K | 0.04% | Mar 17, 2026 |
| Ray Kurzweil | director | 13.3K | 0.03% | Jul 13, 2026 |
| Tommy G. Thompson | director | 8.5K | 0.02% | Mar 26, 2026 |
| Nilda Mesa | director | 5.7K | 0.01% | Jul 13, 2026 |
| Judy D. Olian | director | 5.6K | 0.01% | Jul 13, 2026 |
| Christopher Causey | director | 4.2K | 0.01% | Mar 31, 2026 |
3 people have not refiled in the last 18 months (5.7K shares), so they are not in the figure above
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Aug 27, 2026 | Martine A. Rothblattdirector, officer: Chairperson & CEO | Sale · 18 lots | 9,500 | $522.57 | 324,443 |
| Aug 26, 2026 | Martine A. Rothblattdirector, officer: Chairperson & CEO | Sale · 8 lots | 9,500 | $517.28 | 324,443 |
| Aug 25, 2026 | Martine A. Rothblattdirector, officer: Chairperson & CEO | Sale · 6 lots | 9,500 | $517.71 | 324,443 |
| Aug 24, 2026 | Martine A. Rothblattdirector, officer: Chairperson & CEO | Sale · 5 lots | 9,500 | $511.97 | 324,443 |
| Aug 21, 2026 | Martine A. Rothblattdirector, officer: Chairperson & CEO | Sale · 15 lots | 9,500 | $518.39 | 324,443 |
| Aug 20, 2026 | Martine A. Rothblattdirector, officer: Chairperson & CEO | Sale · 8 lots | 9,500 | $521.02 | 324,443 |
| Aug 20, 2026 | Paul A. Mahonofficer: EVP & GENERAL COUNSEL | Sale · 9 lots | 8,300 | $523.14 | 45,172 |
| Aug 19, 2026 | Martine A. Rothblattdirector, officer: Chairperson & CEO | Sale · 12 lots | 9,500 | $526.96 | 324,443 |
| Aug 18, 2026 | Martine A. Rothblattdirector, officer: Chairperson & CEO | Sale · 10 lots | 9,500 | $515.60 | 324,443 |
| Aug 17, 2026 | Martine A. Rothblattdirector, officer: Chairperson & CEO | Sale · 7 lots | 9,500 | $506.59 | 324,443 |
CongressHouse and Senate disclosures
Not reported.